Abstract
PO0431: Incidence of Adverse Urinary, Gastrointestinal and Sexual Morbidity in Patients Undergoing Combined EBRT and LDR-BT Boost for Unfavorable Intermediate and High Risk Prostate Cancer: Insights from a Singular Institutional Experience
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have